The United States In Vitro Diagnostics (IVD) market is predicted to reach nearly US$ 37 Billion by 2026

NEXT STORY
Emergent BioSolutions Announces Topline Data from NIAID Phase 3 ITAC Trial (INSIGHT-013) Evaluating Immunoglobulins as a Treatment for Hospitalized Patients with COVID-19
PREV STORY
Allarity Therapeutics Submits Premarket Approval Application to U.S. FDA for DRP® Companion Diagnostic for Dovitinib
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Hemispherx Biopharma Management Team: Reflects Company’s Aggressive Commitment to Strategies Designed to Reach Commercial Goals, Preserve Financial Capital, and Increase Stockholder Value

PHILADELPHIA, Feb. 22, 2016 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the “Company” ...

author_avatar
NASDAQ Market News

Philips expands its home care portfolio for COPD patients with first-of-its-kind non-invasive ventilator

author_avatar
NASDAQ Market News

Response Biomedical Announces Strategic Alliances in Japan with Alere Medical and Long Time Partner Shionogi

VANCOUVER, British Columbia, Dec. 8, 2015 (GLOBE NEWSWIRE) -- Response Biomedical Corp. ("Response" or ...

author_avatar
NASDAQ Market News